BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study. - Test2 - elhamkhani - TriplyDB

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.

http://www.wikidata.org/entity/Q34606898

about

Selecting for BRCA1 testing using a combination of homogeneous selection criteria and immunohistochemical characteristics of breast cancers Androgen receptor, EGFR, and BRCA1 as biomarkers in triple-negative breast cancer: a meta-analysis Current advances in biomarkers for targeted therapy in triple-negative breast cancer Characteristics of BRCA1/2 Mutation-Positive Breast Cancers in Korea: A Comparison Study Based on Multicenter Data and the Korean Breast Cancer Registry.Role of BRCA2 mutation status on overall survival among breast cancer patients from Sardinia Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation Carriers.Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery.Wild-type BRCA1, but not mutated BRCA1, regulates the expression of the nuclear form of beta-catenin Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers Possible Relationship between Basal-Like Breast Carcinoma and Age Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer.Prevalence of BRCA1 gene mutation in breast cancer patients in Guangxi, China.Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype.The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers.A novel deleterious PTEN mutation in a patient with early-onset bilateral breast cancer Clinical and molecular characteristics of triple-negative breast cancer patients in Northern Israel: single center experience Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis.Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers: A Review.Haploinsufficiency for BRCA1 leads to cell-type-specific genomic instability and premature senescence.Clinical and pathological features of BRCA1/2 tumors in a sample of high-risk Moroccan breast cancer patients.Association Between BRCA Status and P53 Status in Breast Cancer: A Meta-Analysis BRCA1-hapoinsufficiency: Unraveling the molecular and cellular basis for tissue-specific cancer Response to neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers: a single-institution experience BRCA1/2 mutations and triple negative breast cancers.How, who, and when: preferences for delivery of genome sequencing results among women diagnosed with breast cancer at a young age.Retrospective analysis of breast cancer prognosis among young and older women in a Brazilian cohort of 738 patients, 1985-2002.Triple-negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia.Genetic Susceptibility to ANCA-Associated Vasculitis: State of the Art.Discovering cancer biomarkers from clinical samples by protein microarrays.A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.Contribution of germline mutations in cancer predisposition genes to tumor etiology in young women diagnosed with invasive breast cancer.Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil.Characterization of mutations in BRCA1/2 and the relationship with clinic-pathological features of breast cancer in a hereditarily high-risk sample of chinese population.Role of BRCA Mutations in the Modulation of Response to Platinum Therapy.Risk of having BRCA1 mutation in high-risk women with triple-negative breast cancer: a meta-analysis.High prevalence of BRCA1 founder mutations in Greek breast/ovarian families.Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.Comparison of nodal metastasis between BRCA mutation carriers and non-BRCA mutation carriers with breast cancer.Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study.

P2860

Q21260381-5FA21AF6-D8D9-4760-B8BB-85519B9429AF Q26823419-E2400426-DB15-4AD2-8D1F-E90DD0BE55F3 Q28074202-94FE430E-4A72-4498-A363-1C623D126D97 Q30836057-AA6181B8-D0A4-4324-83F0-253328956727 Q30858718-B8189F34-4204-43D8-8772-9459DF821F87 Q33620683-CCD7C356-F91D-43B7-9113-981327FBE7E7 Q33723561-DDA76BAA-F08E-4C5D-8E8E-499E956EFDAC Q33839776-645DABDF-64E7-4B55-9252-3EFAE9247356 Q33863531-C2796B4B-82ED-4CE6-9452-603692A020B4 Q34095838-5C666E67-3469-4AF8-98A4-C566066BC827 Q34288968-E2C98235-FF63-4456-9647-669E9D7E82C6 Q34371756-BDFF81C7-F4E2-455E-8EBD-31ADBEAA459A Q34978283-A0A57DB7-B0E3-469F-8B8F-E1B1214D3CAC Q35018746-EE55183D-E38A-4578-B44D-7D1CF1808906 Q35086943-4FDAF59F-258C-4191-860C-4CCADB576611 Q35214479-EA5963B8-6FF2-44C4-97E3-248C9262825F Q35224593-CD2780AA-9445-47D2-B444-E5674B6934AF Q35687632-6B9B5896-49EB-4B46-8E60-F5756E4288DC Q35819035-20D7AEB5-7567-4F56-ADE3-DA324AA8D3AC Q36003635-B3FF8D1B-AE4C-4A4B-8543-5EEAF4845770 Q36044042-AE0D6CEE-D05F-4019-AC74-120D7969B424 Q36838404-277BFA61-6A14-4CA3-BA09-AA0E8F73AE1B Q36920416-E6B9B4AC-88BE-4E7A-9099-351E1694C2EF Q37407985-FC5D9D4A-4F7B-48C6-BD51-CE656C467EDD Q37427226-E0540B29-D9A8-4E91-8BE0-8BE5910EFA18 Q37582027-DE60C487-0FDC-4E8C-B298-65B4E289A2E7 Q37652666-BC995B8C-B689-4DF4-B290-C586CCE22590 Q38276417-6689EFB0-83BA-4D15-9F7F-5CA2F133546B Q38293886-4008ED42-5A90-4770-B91A-F2060E3C98AF Q42181679-4DAC127A-666B-49E0-9CF1-11E332102616 Q47763856-7772F563-ED16-4AFF-A22A-169D59BCA7F9 Q47983920-D75ABBA5-FD07-40EC-BC8F-AF9FAE12711C Q49767529-0E8A5466-70FE-4CCC-A1E9-C7776F739F3F Q49829001-F213BE00-C4F6-43AF-A8CA-226458BB9F24 Q51208435-6C5457DE-9A23-4DCB-979C-C7C0122FC079 Q51786624-C8303140-B77B-4F32-AEF0-BA0B7845A9E1 Q53310020-4E48ADF6-4D47-4A0A-8355-1DF275C4A715 Q53829480-A737A9AD-7723-4095-A065-C264A72C537B Q54336161-FFA09D2F-49D9-4564-940F-1F03625EF5ED Q54522260-8064F90E-EB4A-4F8B-AB3D-AACA5CB14856

P2860

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.

http://www.wikidata.org/entity/Q34606898

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

BRCA mutations, molecular mark ...... cer: a population-based study.

@ast

BRCA mutations, molecular mark ...... cer: a population-based study.

@en

BRCA mutations, molecular mark ...... cer: a population-based study.

@nl

type

label

BRCA mutations, molecular mark ...... cer: a population-based study.

@ast

BRCA mutations, molecular mark ...... cer: a population-based study.

@en

BRCA mutations, molecular mark ...... cer: a population-based study.

@nl

prefLabel

BRCA mutations, molecular mark ...... cer: a population-based study.

@ast

BRCA mutations, molecular mark ...... cer: a population-based study.

@en

BRCA mutations, molecular mark ...... cer: a population-based study.

@nl

P1433

Q34606898-FACDE3CC-E33C-4E8D-926B-DC4A710331AE

P1476

Q34606898-6777E9FB-C0D2-4F03-8C09-7B35094F838D

P2093

Q34606898-2C6128E5-0D5C-48CC-BFBE-C383DE9E9C7C

Q34606898-2EB94ABC-16BF-4114-A0CE-CB159B8BB70B

Q34606898-4B6F8E52-D4B3-4743-9CFF-7AEE9D6F3E7C

Q34606898-64ABFE16-455A-42A0-9D42-A993EFE32926

Q34606898-64D76F21-1D98-41E5-A460-2066028183B6

Q34606898-6A3D6C11-540B-43F2-A6A7-D48E08A2467B

Q34606898-A3492D9C-848D-4978-B9D7-307BED457137

Q34606898-B1B68F05-F255-48CA-83C4-C72D506D7010

Q34606898-C1943260-A37D-4767-9084-00065ED8F9BC

Q34606898-DD2C35FB-F01D-4574-8F31-79885F701976

P304

Q34606898-BA654CD9-8D04-41BE-AC65-3BF6360C8C92

P31

Q34606898-9D7C39A3-88A4-49FC-9473-01CEC35C2CDC

P356

Q34606898-78574729-32CA-44EF-B94E-9ADE818D7868

P433

Q34606898-C8F0BEFF-DCEE-483F-B1EA-158F6A1EEDEA

P478

Q34606898-CF288AD4-B566-4E05-8093-C09FF79218E5

P50

Q34606898-0760B54E-9423-4464-84AA-2209C1E96AD0

Q34606898-AF2303AD-F125-4DCA-A9C4-8ACF0E8FE394

P577

Q34606898-9D731468-EDAB-461E-82A2-3437B13C9C9B

P5875

Q34606898-C03EC4B0-3BB5-453C-999F-2D8C3FAABA8D

P698

Q34606898-D2029205-7448-44C4-BC17-F87AD2BC709E

P356

J.BREAST.2006.12.003

P1433

P1476

BRCA mutations, molecular mark ...... ncer: a population-based study

@en

P2093

Andrea Ardizzoni

http://www.w3.org/2001/XMLSchema#string

Beatrice Bortesi

http://www.w3.org/2001/XMLSchema#string

Debora Pezzuolo

http://www.w3.org/2001/XMLSchema#string

Maria A Bella

http://www.w3.org/2001/XMLSchema#string

Maria Michiara

http://www.w3.org/2001/XMLSchema#string

Mario Savi

http://www.w3.org/2001/XMLSchema#string

Nadia Naldi

http://www.w3.org/2001/XMLSchema#string

Paola Zanelli

http://www.w3.org/2001/XMLSchema#string

Roberta Camisa

http://www.w3.org/2001/XMLSchema#string

Tauro M Neri

http://www.w3.org/2001/XMLSchema#string

P304

280-292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BREAST.2006.12.003

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Marzia Capelletti

P577

2007-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6546069

http://www.w3.org/2001/XMLSchema#string

P698

17257844

http://www.w3.org/2001/XMLSchema#string